Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Multi-factors including Inflammatory/Immune, Hormones, Tumor-related Proteins and Nutrition associated with Chronic Prostatitis NIH IIIa+b and IV based on FAMHES project.

Chen Y, Li J, Hu Y, Zhang H, Yang X, Jiang Y, Yao Z, Chen Y, Gao Y, Tan A, Liao M, Lu Z, Wu C, Xian X, Wei S, Zhang Z, Chen W, Wei GH, Wang Q, Mo Z.

Sci Rep. 2017 Aug 22;7(1):9143. doi: 10.1038/s41598-017-09751-8.

2.

Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.

Magri V, Trinchieri A, Montanari E, Del Nero A, Mangiarotti B, Zirpoli P, de Eguileor M, Marras E, Ceriani I, Vral A, Perletti G.

Arch Ital Urol Androl. 2007 Jun;79(2):84-92.

PMID:
17695414
3.

Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS.

Schneider H, Brähler E, Ludwig M, Hochreiter W, Collins MF, Eremenco S, Weidner W.

Urology. 2004 Jun;63(6):1027-30.

PMID:
15183940
5.

Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.

Magri V, Marras E, Restelli A, Wagenlehner FM, Perletti G.

Exp Ther Med. 2015 Mar;9(3):658-666. Epub 2014 Dec 19.

6.

Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.

Vicari E, Salemi M, Sidoti G, Malaguarnera M, Castiglione R.

Nutrients. 2017 Nov 3;9(11). pii: E1208. doi: 10.3390/nu9111208.

7.

Influence of environmental factors on prevalence, symptoms, and pathologic process of chronic prostatitis/chronic pelvic pain syndrome in northwest China.

Lan T, Wang Y, Chen Y, Qin W, Zhang J, Wang Z, Zhang W, Zhang X, Yuan J, Wang H.

Urology. 2011 Nov;78(5):1142-9. doi: 10.1016/j.urology.2011.04.066.

PMID:
22054390
9.

Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center.

Zhang Y, Zheng T, Tu X, Chen X, Wang Z, Chen S, Yang Q, Wan Z, Han D, Xiao H, Sun X, Deng C.

PLoS One. 2016 Apr 27;11(4):e0153054. doi: 10.1371/journal.pone.0153054. eCollection 2016.

10.

Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Magri V, Wagenlehner FM, Marras E, VAN Till JW, Houbiers J, Panagopoulos P, Petrikkos GL, Perletti G.

Exp Ther Med. 2013 Aug;6(2):503-508. Epub 2013 Jun 21.

11.

Effect of antibiotic therapy on interleukin-6 in fresh semen and postmasturbation urine samples of patients with chronic prostatitis/chronic pelvic pain syndrome.

Stancik I, Plas E, Juza J, Pflüger H.

Urology. 2008 Aug;72(2):336-9. doi: 10.1016/j.urology.2008.04.005. Epub 2008 May 12.

PMID:
18468661
12.

Heat-shock protein 70 expression in the seminal plasma of patients with chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome.

Guo H, Xu YM, Ye ZQ, Yu JH, Fu Q, Sa YL, Hu XY, Song LJ.

Prostate Cancer Prostatic Dis. 2010 Dec;13(4):338-42. doi: 10.1038/pcan.2010.22. Epub 2010 Jun 29.

PMID:
20585345
13.

Reliability and validity of the National Institutes of Health: Chronic Prostatitis Symptom Index in a Malaysian population.

Cheah PY, Liong ML, Yuen KH, Lee S, Yang JR, Teh CL, Khor T, Yap HW, Krieger JN.

World J Urol. 2006 Feb;24(1):79-87. Epub 2006 Feb 8.

PMID:
16465553
14.

Oxidative stress--cause or consequence of male genital tract disorders?

Kullisaar T, Türk S, Punab M, Mändar R.

Prostate. 2012 Jun 15;72(9):977-83. doi: 10.1002/pros.21502. Epub 2011 Oct 24.

PMID:
22025397
15.
17.

Experience with different questionnaires in the management of patients with CP/CPPS: GPSS, IPSS and NIH-CPSI.

Schneider H, Ludwig M, Weidner W, Brähler E.

World J Urol. 2003 Aug;21(3):116-8; discussion 115. Epub 2003 May 24.

PMID:
12768318
18.

Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment.

Watanabe T, Inoue M, Sasaki K, Araki M, Uehara S, Monden K, Saika T, Nasu Y, Kumon H, Chancellor MB.

BJU Int. 2011 Jul;108(2):248-51. doi: 10.1111/j.1464-410X.2010.09716.x. Epub 2010 Sep 30.

19.

Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.

Morgia G, Mucciardi G, Galì A, Madonia M, Marchese F, Di Benedetto A, Romano G, Bonvissuto G, Castelli T, Macchione L, Magno C.

Urol Int. 2010;84(4):400-6. doi: 10.1159/000302716. Epub 2010 Mar 24.

PMID:
20332612
20.

Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome.

Nadler RB, Collins MM, Propert KJ, Mikolajczyk SD, Knauss JS, Landis JR, Fowler JE Jr, Schaeffer AJ, Alexander RB; Chronic Prostatitis Collaborative Research Network.

Urology. 2006 Feb;67(2):337-42. Epub 2006 Jan 25.

PMID:
16442595

Supplemental Content

Support Center